BioXcel Therapeutics, Inc.: cash_and_equivalents
| Value | {"amount": 36296000, "concept": "us-gaap:CashAndCashEquivalentsAtCarryingValue", "currency": "USD"} |
|---|---|
| Period | (as of 2019-03-31) |
| Status | current |
| Entity | BioXcel Therapeutics, Inc. |
Provenance
Source: SEC EDGAR CompanyFacts (US-PD-17USC105)
Reference:
Retrieved: 2026-08-19T17:36:07.356361+02:00
Raw response sha256:
Also addressable by official identifiers:
Cite as: FACTANKER, https://factanker.com/fact/f48224af-e5d2-4218-b534-fc477f02fff9
Source: SEC EDGAR CompanyFacts (US-PD-17USC105)
Reference:
0001558370-19-004262Retrieved: 2026-08-19T17:36:07.356361+02:00
Raw response sha256:
f7bde1a401b286c74a2fd824ee1df541…Also addressable by official identifiers:
https://factanker.com/fact/sec/cik-0001720893/cash-and-equivalents/2019-03-31 (CIK, metric, reporting date)Cite as: FACTANKER, https://factanker.com/fact/f48224af-e5d2-4218-b534-fc477f02fff9
History
- no predecessors — first report